NUVELO, INC.

Company

Oruka Therapeutics, Inc.

Filed

May 16, 2008

Accession Number

0000950135-08-003756

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →